Concepedia

Fas counter-attack–the best form of tumor defense?

Joe O’Connell, Michael W. Bennett, G O'Sullivan, John Collins, Fergus Shanahan

Nature Medicine · 1999 · 73 citations · 12 references

DOI

Concepts

References

12

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

Michael Hahne, Donata Rimoldi, Michael Schröter et al. · Science · 1996 · 1.3K citations

, , +17

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.

J O’Connell, Gerald C. O’Sullivan, John Collins et al. · The Journal of Experimental Medicine · 1996 · 890 citations · Full text

, , +17

Downregulation of Fas ligand by shedding

Masato Tanaka, Toshimitsu Itai, Masashi Adachi et al. · Nature Medicine · 1998 · 675 citations

, , +12

CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance

Thomas S. Griffith, Xinhong Yu, John M. Herndon et al. · Immunity · 1996 · 390 citations · Full text

, , +12

Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)

Jianjun Chen, Yongnian Sun, Gary J. Nabel · Science · 1998 · 383 citations

, , +17